CN Patent

CN103003275A — Vmat2的苯并喹啉酮抑制剂

Assigned to Auspex Pharmaceuticals Inc · Expires 2013-03-27 · 13y expired

What this patent protects

本发明涉及VMAT2的新型苯并喹啉酮抑制剂、其药物组合物和其使用方法。式(I)

USPTO Abstract

本发明涉及VMAT2的新型苯并喹啉酮抑制剂、其药物组合物和其使用方法。式(I)

Drugs covered by this patent

valbenazine-tosylate (VALBENAZINE TOSYLATE)

Patent Metadata

Patent number: CN103003275A
Jurisdiction: CN
Classification: —
Expires: 2013-03-27
Drug substance claim: No
Drug product claim: No
Assignee: Auspex Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.